|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Divisions of Pulmonary and Critical Care Medicine (Drs. Yusen and Lefrak) and Cardiothoracic Surgery (Drs. Meyers, Patterson, Cooper, and Ms. Davis), and Mallinckrodt Institute of Radiology (Dr. Gierada), Washington University School of Medicine, and Barnes-Jewish Hospital, St. Louis, MO.
Correspondence to: Roger D. Yusen, MD, MPH, FCCP, Washington University School of Medicine, Box 8052, 660 S. Euclid Ave, St. Louis, MO 63110; e-mail: yusenr{at}msnotes.wustl.edu
Objectives: Though numerous studies have demonstrated the short-term efficacy of lung volume reduction surgery (LVRS) in select patients with emphysema, the longer-term follow-up studies are just being reported. The primary objectives of this study were to assess long-term health-related quality of life, satisfaction, physiologic status, and survival of patients following LVRS.
Design: We used a prospective cohort study design to assess the first 200 patients undergoing bilateral LVRS (from 1993 to 1998), with follow-up through the year 2000. Each patient served as his own control, initially receiving optimal medical management including exercise rehabilitation before undergoing surgery. Preoperative postrehabilitation data were used as the baseline for comparisons with postoperative data. The primary end points were the effects of LVRS on dyspnea (modified Medical Research Council dyspnea sale), general health-related quality of life (Medical Outcomes Study 36-Item Short-Form Health Survey [SF-36]), patient satisfaction, and survival. The secondary end points were the effects of LVRS on pulmonary function, exercise capacity, and supplemental oxygen requirements.
Setting: A tertiary care urban university-based referral center.
Patients: Eligibility requirements for LVRS included disabling dyspnea due to marked airflow obstruction, thoracic hyperinflation, and heterogeneously distributed emphysema that provided target areas for resection. Patients were assessed at 6 months, 3 years, and 5 years after surgery.
Interventions: Preoperative pulmonary rehabilitation and bilateral stapling LVRS.
Measurements and results: The 200 patients accrued 735 person-years (mean ± SD, 3.7 ± 1.6 years; median, 4.0 years) of follow-up. Over the three follow-up periods, an average of > 90% of evaluable patients completed testing. Six months, 3 years, and 5 years after surgery, dyspnea scores were improved in 81%, 52%, and 40% of patients, respectively. Dyspnea scores were the same or improved in 96% (6 months), 82% (3 years), and 74% (5 years) of patients. Improvements in SF-36 physical functioning were demonstrated in 93% (6 months), 78% (3 years), and 69% (5 years) of patients. Good-to-excellent satisfaction with the outcomes was reported by 96% (6 months), 89% (3 years), and 77% (5 years) of patients. The FEV1 was improved in 92% (6 months), 72% (3 years), and 58% (5 years) of patients. Changes in dyspnea and general health-related quality-of-life scores, and patient satisfaction scores were all significantly correlated with changes in FEV1. Following surgery, the median length of hospital stay in survivors was 9 days. The 90-day postoperative mortality was 4.5%. Annual Kaplan-Meier survival through 5 years after surgery was 93%, 88%, 83%, 74%, and 63%, respectively. During follow-up, 15 patients underwent subsequent lung transplantation.
Conclusions: In stringently selected patients, LVRS resulted in substantial beneficial effects over and above those achieved with optimized medical therapy. The duration of improvement was at least 5 years in the majority of survivors.
Key Words: airflow obstruction bullectomy COPD dyspnea emphysema lung volume reduction outcomes research personal satisfaction pneumonectomy quality of life thoracic surgery
This article has been cited by other articles:
![]() |
N. Shigemura, M. Okumura, S. Mizuno, Y. Imanishi, A. Matsuyama, H. Shiono, T. Nakamura, and Y. Sawa Lung Tissue Engineering Technique with Adipose Stromal Cells Improves Surgical Outcome for Pulmonary Emphysema Am. J. Respir. Crit. Care Med., December 1, 2006; 174(11): 1199 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Mineo, E. Pompeo, D. Mineo, V. Ambrogi, D. Ciarapica, and A. Polito Resting energy expenditure and metabolic changes after lung volume reduction surgery for emphysema. Ann. Thorac. Surg., October 1, 2006; 82(4): 1205 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Venuta, E. A. Rendina, T. De Giacomo, M. Anile, D. Diso, C. Andreetti, F. Pugliese, and G. F. Coloni Bronchoscopic procedures for emphysema treatment Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 281 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Y. P. Wan, T. P. Toma, D. M. Geddes, G. Snell, T. Williams, F. Venuta, and A. P. C. Yim Bronchoscopic Lung Volume Reduction for End-Stage Emphysema: Report on the First 98 Patients Chest, March 1, 2006; 129(3): 518 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Gorman, D. K. McKenzie, J. E. Butler, J. F. Tolman, and S. C. Gandevia Diaphragm Length and Neural Drive after Lung Volume Reduction Surgery Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1259 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Palla, M. Desideri, G. Rossi, G. Bardi, D. Mazzantini, A. Mussi, and C. Giuntini Elective Surgery for Giant Bullous Emphysema: A 5-Year Clinical and Functional Follow-up Chest, October 1, 2005; 128(4): 2043 - 2050. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Myint, R. N. Luben, P. G. Surtees, N. W. J. Wainwright, A. A. Welch, S. A. Bingham, N. J. Wareham, N. E. Day, and K-T. Khaw Respiratory function and self-reported functional health: EPIC-Norfolk population study Eur. Respir. J., September 1, 2005; 26(3): 494 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Mineo, V. Ambrogi, D. Mineo, A. Fabbri, E. Fabbrini, and R. Massoud Bone Mineral Density Improvement After Lung Volume Reduction Surgery for Severe Emphysema Chest, June 1, 2005; 127(6): 1960 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Yusen and B. Littenberg Integrating Survival and Quality of Life Data in Clinical Trials of Lung Disease: The Case of Lung Volume Reduction Surgery Chest, April 1, 2005; 127(4): 1094 - 1096. [Full Text] [PDF] |
||||
![]() |
N. S. Hopkinson, T. P. Toma, D. M. Hansell, P. Goldstraw, J. Moxham, D. M. Geddes, and M. I. Polkey Effect of Bronchoscopic Lung Volume Reduction on Dynamic Hyperinflation and Exercise in Emphysema Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 453 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Mineo, E. Pompeo, D. Mineo, P. Rogliani, C. Leonardis, and I. Nofroni Results of unilateral lung volume reduction surgery in patients with distinct heterogeneity of emphysema between lungs J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 73 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Nathan, L. B. Edwards, S. D. Barnett, S. Ahmad, and N. A. Burton Outcomes of COPD Lung Transplant Recipients After Lung Volume Reduction Surgery Chest, November 1, 2004; 126(5): 1569 - 1574. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brenner, N. M. Hanna, R. Mina-Araghi, A. F. Gelb, R. J. McKenna Jr, and H. Colt Innovative Approaches to Lung Volume Reduction for Emphysema Chest, July 1, 2004; 126(1): 238 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. C. Yim, T. M. T. Hwong, T. W. Lee, W. W. L. Li, S. Lam, T. K. Yeung, D. S. C. Hui, F. W. S. Ko, A. D. L. Sihoe, K. H. Thung, et al. Early results of endoscopic lung volume reduction for emphysema J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1564 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pompeo, D. Mineo, P. Bollero, P. Rogliani, V. Ambrogi, and T. C. Mineo Completion lobectomy after bilateral lung volume reduction for emphysema: Salvage option or fancy? J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1212 - 1214. [Full Text] [PDF] |
||||
![]() |
B. F. Meyers, R. D. Yusen, T. J. Guthrie, G. A. Patterson, S. S. Lefrak, G. E. Davis, and J. D. Cooper Results of lung volume reduction surgery in patients meeting a National Emphysema Treatment Trial high-risk criterion J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 829 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.C. Mineo, V. Ambrogi, E. Pompeo, S. Elia, D. Mineo, P. Bollero, and I. Nofroni Impact of lung volume reduction surgery versus rehabilitation on quality of life Eur. Respir. J., February 1, 2004; 23(2): 275 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Maxfield New and Emerging Minimally Invasive Techniques for Lung Volume Reduction Chest, February 1, 2004; 125(2): 777 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
D A Lomas Lung volume reduction surgery: where are we now? Chronic Respiratory Disease, January 1, 2004; 1(1): 2 - 4. [PDF] |
||||
![]() |
E. Pompeo, E. De Dominicis, V. Ambrogi, D. Mineo, S. Elia, and T. C. Mineo Quality of life after tailored combined surgery for stage I non-small-cell lung cancer and severe emphysema Ann. Thorac. Surg., December 1, 2003; 76(6): 1821 - 1827. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |